{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:58:56Z","timestamp":1788044336059,"version":"build-2784847793"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"United States National Institutes of Health","award":["R01 HL 155519"],"award-info":[{"award-number":["R01 HL 155519"]}]},{"name":"United States National Institutes of Health","award":["R01 HL146373"],"award-info":[{"award-number":["R01 HL146373"]}]},{"name":"United States National Institutes of Health","award":["R35 HL150818"],"award-info":[{"award-number":["R35 HL150818"]}]},{"name":"United States National Institute of Biomedical Imaging and Bioengineering","award":["R01 HL 155519"],"award-info":[{"award-number":["R01 HL 155519"]}]},{"name":"United States National Institute of Biomedical Imaging and Bioengineering","award":["R01 HL146373"],"award-info":[{"award-number":["R01 HL146373"]}]},{"name":"United States National Institute of Biomedical Imaging and Bioengineering","award":["R35 HL150818"],"award-info":[{"award-number":["R35 HL150818"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Platelet glycoprotein (GP)VI is a transmembrane protein that was originally characterized as a collagen receptor supporting platelet adhesion and activation through its association with the Fc receptor \u03b3-chain (FcR\u03b3). The FcR\u03b3 subunit contains immunoreceptor tyrosine-based activation motifs (ITAMs) that recruit and activate Syk (spleen tyrosine kinase), a key player in intracellular signaling pathways. The absence or dysfunction of GPVI produces a mild bleeding defect in humans like the impaired hemostasis reported in the murine knockout. Here, we took an ultrastructure approach to examine the impact of ligand binding to GPVI versus the downstream pharmacologic inhibition of the GPVI-dependent ITAM signaling pathway. Clots were generated for analysis following a puncture wound in the mouse external jugular vein. Images were obtained using mice genetically missing GPVI and mice pretreated with the Syk inhibitor, BI 1002494. Our study was designed to test the hypothesis that the predominant contribution of GPVI to hemostasis is mediated by a Syk-dependent signaling cascade. If true, the clot structure observed with a Syk inhibitor versus the GPVI knockout would be similar. If the extracellular domains of the protein had a Syk-independent platelet adhesion role, then significant comparative differences in the thrombus structure would be expected. Our results clearly indicate an important, Syk-independent role of the GPVI extracellular domain in the adherence of platelets within the intravascular crown of a growing venous clot, a site distant from exposed collagen-rich adventitia. In striking contrast, the adventitial proximal role of GPVI was Syk-dependent, with the GPVI knockout and Syk inhibitor giving the same, limited structural outcome of collagen-proximal platelet cytosol loss and a thinned extravascular cap. Consistent with the lesser role of Syk-dependent processes on the thrombus structure, the Syk inhibitor had no detectable effect on jugular puncture wound bleeding times, while the knockout had a statistically significant, but modest effect on bleeding time. Based on this contrast, we suggest that Syk inhibition may be the more selective approach to modulating the role of GPVI in occlusive clotting.<\/jats:p>","DOI":"10.3390\/ijms26094294","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:16:12Z","timestamp":1746090972000},"page":"4294","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Contrasting Effects of Platelet GPVI Deletion Versus Syk Inhibition on Mouse Jugular Vein Puncture Wound Structure"],"prefix":"10.3390","volume":"26","author":[{"given":"Irina D.","family":"Pokrovskaya","sequence":"first","affiliation":[{"name":"Department of Physiology and Cell Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 77205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Ball","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 77205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Webb","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 77205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung W.","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-6338","authenticated-orcid":false,"given":"Jerry","family":"Ware","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 77205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Storrie","sequence":"additional","affiliation":[{"name":"Department of Physiology and Cell Biology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 77205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: Is GPVI the central receptor","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.jtha.2023.03.022","article-title":"Glycoprotein VI interplay with fibrin(ogen) in thrombosis","volume":"21","author":"Mangin","year":"2023","journal-title":"J. Throm. Haemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/bj3110471","article-title":"Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc gamma-IIA receptor","volume":"311","author":"Yanaga","year":"1995","journal-title":"Biochem J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(97)00926-5","article-title":"Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain","volume":"413","author":"Gibbins","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23528","DOI":"10.1074\/jbc.272.38.23528","article-title":"A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets","volume":"272","author":"Tsuji","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1538-7836.2010.03875.x","article-title":"GPVI and CLEC2 in hemostasis and vascular integrity","volume":"8","author":"Watson","year":"2010","journal-title":"J. Throm. Hamost."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI122955","article-title":"Functional significance of the platelet immune receptors GPVI and CLEC-2","volume":"129","author":"Reyes","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood.V69.6.1712.1712","article-title":"A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia","volume":"69","author":"Sugiyama","year":"1987","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"29019","DOI":"10.1074\/jbc.274.41.29019","article-title":"The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors","volume":"274","author":"Clemetson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI114318","article-title":"A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion","volume":"84","author":"Moroi","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.V91.2.491","article-title":"Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb\/IIIa, and von Willebrand factor do not","volume":"91","author":"Kehrel","year":"1998","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2003-03-0717","article-title":"The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion","volume":"102","author":"Kato","year":"2003","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/ATVBAHA.115.306883","article-title":"The novel oral Syk inhibitor, Bl1002494, protects mice from arterial thrombosis and thromboinflammatory brain infarction","volume":"36","author":"Stegner","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rhee, S.W., Pokrovskaya, I.D., Ball, K.K., Webb, M.W., Kamykowski, J.A., Zhao, O., Driehaus, E.R., Aronova, M.A., Whiteheart, S.W., and Leapman, R.D. (2024). Single-platelet mapping of jugular, puncture-wound thrombi reveal the spatial evolution of platelet activation. bioRxiv.","DOI":"10.1101\/2024.07.07.602390"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rhee, S.W., Pokrovskaya, I.D., Ball, K.K., Ling, K., Vedanaparti, Y., Cohen, J., Cruz, D.R., Zhao, O.S., Aronova, M.A., and Zhang, G. (2021). Venous puncture wound hemostasis results in a vaulted thrombus structured by locally nucleated platelet aggregates. Commun. Biol., 4.","DOI":"10.1038\/s42003-021-02615-y"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu. Rev. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10822","DOI":"10.1074\/jbc.270.18.10822","article-title":"Interaction of the von Willebrand factor (vWF) with collagen","volume":"270","author":"Cruz","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_18","first-page":"611616","article-title":"Mechanisms initiating platelet thrombus formation","volume":"78","author":"Ruggeri","year":"1997","journal-title":"Throm. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1160\/TH07-10-0638","article-title":"Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice","volume":"99","author":"Bergmeier","year":"2008","journal-title":"Throm. Haemost."},{"key":"ref_20","first-page":"S9","article-title":"VWF attributes\u2014Impact on thrombus formation","volume":"122","author":"Reininger","year":"2008","journal-title":"Haemophilia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e12564","DOI":"10.1002\/rth2.12564","article-title":"A tail of two ITAMs: GPVI\/FcR\u03b3 and FcgRIa\u2019s role in platelet activation and thrombus stability","volume":"5","author":"Neeves","year":"2021","journal-title":"Res. Pract. Throm. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/09537104.2020.1849600","article-title":"Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases","volume":"32","author":"Harbi","year":"2022","journal-title":"Platelets"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Navarro, S., Stark, A., Haemskerk, J.W.M., Kuijpers, M.J.E., Stegner, D., and Neiswandt, B. (2022). Targeting of a conserved epitope in mouse and human GPVI differently affects receptor function. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158610"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Fuentes, E. (2022). Modulation of glycoprotein VI and its downstream signaling pathways as an antiplalelet target. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179882"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jtha.2024.12.003","article-title":"New targets for antithrombotic medications: Seeking to decouple thrombosis from hemostasis","volume":"23","author":"Barnes","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ehjcvp\/pvae018","article-title":"GPVI inhibition: Advancing antithrombotic therapy in cardiovascular disease","volume":"10","author":"Slater","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"100058","DOI":"10.1016\/j.rpth.2023.100058","article-title":"Tethered platelet capture provides a mechanism for restricting circulating platelet activation to the wound site","volume":"7","author":"Pokrovskaya","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_29","first-page":"e66479","article-title":"Puncture wound hemostasis and preparation of samples for montaged wide-area microscopy analysis","volume":"207","author":"Ball","year":"2024","journal-title":"J. Vis. Exp."},{"key":"ref_30","unstructured":"Faruque, O., Pokrovskaya, I.D., Ball, K.K., Webb, M.W., Rhee, S.W., and Storrie, B. (Blood VTH, 2025). The Syk inhibitor Bi 1002494 selectively impairs thrombus infill in a murine femoral artery occlusion model without affecting puncture wound thrombus structure, Blood VTH, in revision."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4294\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:25:50Z","timestamp":1760030750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26094294"],"URL":"https:\/\/doi.org\/10.3390\/ijms26094294","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}